← Back to Search

Physical Activity Prescription for Post-ACL Reconstruction Recovery

N/A

Recruiting

Led By Jane Thornton, MD PhD

Research Sponsored by Western University, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will investigate the effect of a physical activity prescription delivered through a mobile app on patient-reported outcomes and cartilage health in individuals 5-10 years post-ACL reconstruction.

Who is the study for?

This trial is for individuals who are 7 years post-ACL reconstruction surgery and part of the STAbiLiTY study. They must have internet and smartphone access, be stable enough to engage in physical activity, willing to follow up during the study period, and communicate in English.Check my eligibility

What is being tested?

The trial is testing a Physical Activity Prescription (PARx) intervention aimed at improving knee health after ACL reconstruction. It investigates whether regular prescribed exercise can prevent or delay osteoarthritis by promoting better cartilage health.See study design

What are the potential side effects?

While specific side effects aren't listed for PARx, increased physical activity could potentially lead to muscle soreness, joint pain, or exacerbation of existing knee issues if not done carefully.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

International Knee Documentation Committee (IKDC)

Secondary outcome measures

Knee Injury and Osteoarthritis Outcome Score

Physical Activity Evaluation using Global Physical Activity Questionnaire (GPAQ) and MyRecovery app

Three-dimensional Motion-captured Gait Biomechanics Analysis

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Physical Activity Prescription (PARx)Experimental Treatment1 Intervention

Patients will be prescribed technology-based physical activity programming.

Group II: Usual CareActive Control1 Intervention

Patients will receive the usual care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor

239 Previous Clinical Trials

57,287 Total Patients Enrolled

Jane Thornton, MD PhDPrincipal InvestigatorWestern University

1 Previous Clinical Trials

192 Total Patients Enrolled

Media Library

Physical Activity Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05152758 — N/A

Anterior Cruciate Ligament Reconstruction Research Study Groups: Physical Activity Prescription (PARx), Usual Care

Anterior Cruciate Ligament Reconstruction Clinical Trial 2023: Physical Activity Intervention Highlights & Side Effects. Trial Name: NCT05152758 — N/A

Physical Activity Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05152758 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment count for this clinical research?

"Affirmative. Clinicaltrials.gov reflects that this study, first posted on the 1st of November 2021, is actively searching for participants to enrol in their trial. In total 196 patients will be needed at a solitary medical centre."

Answered by AI

Is the research open to individuals of advanced age?

"This research study is specifically targeting participants aged 21 to 32. Persons under 18 years old are limited to only 32 trials, whereas there are 587 for those over 65."

Answered by AI

Are there any open enrollment slots for this research project?

"Affirmatively, this clinical trial is actively seeking patients. It was first published on November 1st 2021 and revised most recently the 28th of that same month."

Answered by AI

Does my profile meet the requirements to join this experiment?

"To be eligible for this medical experiment, patients should have had a previous anterior cruciate ligament reconstruction and possess ages from 21 to 32. A total of 196 participants are needed for the study's success."

Answered by AI

Recent research and studies

World Journal of OrthopedicsJournal

Exercise as Medicine to Be Prescribed in Osteoarthriti

Ravalli, Silvia, Paola Castrogiovanni, and Giuseppe Musumeci. 2019. “Exercise as Medicine to Be Prescribed in Osteoarthriti”. World Journal of Orthopedics. Baishideng Publishing Group Inc.. doi:10.5312/wjo.v10.i7.262.

Medicine & Science in Sports & ExerciseJournal

Effects of Physical Activity in Knee and Hip Osteoarthritis: A Systematic Umbrella Review

KRAUS, VIRGINIA B., KYLE SPROW, KENNETH E. POWELL, DAVID BUCHNER, BONNY BLOODGOOD, KATRINA PIERCY, STEPHANIE M. GEORGE, and WILLIAM E. KRAUS. 2019. “Effects of Physical Activity in Knee and Hip Osteoarthritis: A Systematic Umbrella Review”. Medicine & Science in Sports & Exercise. Ovid Technologies (Wolters Kluwer Health). doi:10.1249/mss.0000000000001944.

Osteoarthritis and CartilageJournal

Osteoarthritis Year in Review 2019: Rehabilitation and Outcomes

Maly, M.R., K.A. Marriott, and J.N. Chopp-Hurley. 2020. “Osteoarthritis Year in Review 2019: Rehabilitation and Outcomes”. Osteoarthritis and Cartilage. Elsevier BV. doi:10.1016/j.joca.2019.11.008.

The American Journal of Sports MedicineJournal